Cleared Traditional

Viva Nasal Mask (Model: NM4), Numa Full Face Mask (Model: BMC-FM2) (K163464) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
270d
Days
Class 2
Risk

K163464 is an FDA 510(k) clearance for the Viva Nasal Mask (Model: NM4), Numa Full Face Mask (Model: BMC-FM2). Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Bmc Medical., Ltd. (Haidian, CN). The FDA issued a Cleared decision on September 5, 2017 after a review of 270 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bmc Medical., Ltd. devices

Submission Details

510(k) Number K163464 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 2016
Decision Date September 05, 2017
Days to Decision 270 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
130d slower than avg
Panel avg: 140d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 208
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K163464.
Bleep DreamPort
K172335 · Snapcpap · Mar 2018
AirFit F20
K170924 · Resmed, Ltd. · Jan 2018
AirFit N20
K171212 · Resmed, Ltd. · Sep 2017
Menai System
K160836 · Resmed, Ltd. · Dec 2016
AirFit N20
K161978 · Resmed, Ltd. · Nov 2016
S9 VPAP Adapt, VPAP Adapt, AirCurve 10 ASV
K160822 · Resmed, Ltd. · Sep 2016